Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2025-12-24 @ 5:05 PM
NCT ID:
NCT06759350
Eligibility Criteria:
Inclusion Criteria:
* Submission of a signed and dated informed consent form.
* Declared willingness to comply with all study procedures and availability for the duration of the study.
* Can read and write
* Female, age 45 to 65 years
* Female with more than 1 year of amenorrhea.
* No hormone replacement therapy or herbal medications in the 6 months prior to the investigation.
* Ability to take oral medication and willing to comply with the \<study intervention regimen.
* Agreement to comply with Lifestyle Considerations for the duration of the study.
* Have a smartphone-type cell phone
* Residence in Francisco Morazán
Exclusion Criteria:
* Patient does not sign informed consent
* Patient does not wish to participate
* History of thrombo embolism
* History of cardiovascular disease
* Presence of estrogen-dependent neoplasm
* Presence of abnormal genital bleeding
* Uncontrolled metabolic diseases
* Smoking and drinking habits
* Use of anticoagulant or acetylsalicylic acid
* Known allergic reactions to soy isoflavonate components
* History of thrombophilias such as: Antithrombin deficiency, Protein C deficiency, Protein S deficiency, Factor V Leiden, Prothrombin G20210A, Hyperhomocysteinemia, Antiphospholipid syndrome, Acquired activated protein C resistance.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
45 Years
Maximum Age:
65 Years
Study:
NCT06759350
Study Brief:
Protocol Section:
NCT06759350